SEC Company Response from Celularity Inc (CELU, CELUW) (CIK 0001752828) (CELU) — Apr 26, 2019
Celularity Inc (CELU, CELUW) (CIK 0001752828)
Date: April 26, 2019 · CIK: 0001752828 · Accession: 0001213900-19-007208
AI Filing Summary & Sentiment
Show Raw Text
CORRESP
1
filename1.htm
April 26, 2019
VIA
EDGAR
U.S.
Securities and Exchange Commission
100
F Street, N.E.
Division
of Corporation Finance Office
of
Transportation and Leisure
Washington,
D.C. 20549
Attn:
Jay Ingram
Re: GX
Acquisition Corp.
Draft
Registration Statement on Form S-1
Submitted
November 5, 2018
CIK
No. 1752828
Dear
Mr. Ingram:
GX
Acquisition Corp. (the “Corporation,” “we,” “our” or “us”) hereby transmits its
response to the comment letter received from the staff (the “Staff”) of the Securities and Exchange Commission (the
“Commission”), dated April 10, 2019, regarding the revised Draft Registration Statement on Form S-1 submitted on March
28, 2019.
For
the Staff’s convenience, we have repeated below the Staff’s comments in bold, and have followed each comment with
the Company’s response.
Form
DRS/A submitted 3/28/2019
General
1. We
note that your forum selection provision identifies the Court of Chancery of the State
of Delaware and the federal district court for the District of Delaware as the exclusive
forum for any action arising under the Securities Act. Please revise your disclosure
to highlight the uncertainty relating to the enforceability of such a provision.
We
have revised the indicated disclosure per the Staff’s request.
We
thank the Staff in advance for its consideration of these changes. Should you have any questions regarding the foregoing, please
contact our outside counsel, Stuart Neuhauser, Esq. of Ellenoff Grossman & Schole LLP at (212) 370-1300.
Sincerely,
By:
/s/ Jay R. Bloom
Name:
Jay R. Bloom
cc:
Stuart Neuhauser, Esq.